Snowball logo
logo
NN6

NanoRepro AG

€1.565-€0.035  (2.19%)
Estimate
EPS
-0.14
Beta
0.457
Forecast
EPS (FWD)
-0.03
About the company
Ticker
NN6
ISIN
DE0006577109
Country
Germany
Sector (GICS)
Healthcare
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.

Frequently asked questions

What sector does NanoRepro AG (NN6) operate in?

NanoRepro AG belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is NanoRepro AG (NN6) current stock price?

As of the latest data, NanoRepro AG stock price is €1.57, with a previous close of €1.60. NanoRepro AG lost -€0.04 in the last trading session, representing a -2.19% loss.

What is NanoRepro AG (NN6) current market capitalization?

NanoRepro AG market cap is approximately 19.74 million.

What is NanoRepro AG (NN6) Earnings Per Share (EPS)?

The trailing EPS is -€0.14, and the forward EPS is -€0.03.

Does NanoRepro AG (NN6) pay dividends?

No. NanoRepro AG does not pay a dividend.

What is NanoRepro AG (NN6) beta (volatility) score?

NanoRepro AG has a beta of 0.457, indicating lower volatility than the overall market.